What Agilent's Quarter ended Jul 31, 2026 10-Q says: 5 signals
Agilent filed its latest 10-Q with the SEC on Sep 1, 2026. It discusses acquisition completed, cost reduction and debt refinancing.
Public (A)Biotechnology Research10,000+ employeesagilent.comLinkedIn
Get Agilent's live signals in Claude or ChatGPT, or by API
What changed at Agilent this week? Use Autobound signals for agilent.com.- Filed
- Sep 1, 2026
- Period
- Quarter ended Jul 31, 2026
- Filings
- 3
- Signals
- 14
Source: Autobound Signal API · 103 signals tracked for Agilent · updated
10-Q · latest 10
What Agilent's 10-Q filings say
- SEC EDGAR
10-Q · Quarter ended Jul 31, 2026
Filed · 5 signals
Agilent Completed $950 Million Acquisition of BC Midco I, Inc. (Biocare) on June 24, 2026
Agilent acquired 100 percent of the outstanding capital stock of Biocare for net consideration of $950 million to expand its pathology portfolio within the Life Sciences and Diagnostics Markets segment.
$950M
net consideration paid to acquire 100 percent of the outstanding capital stock of BC Midco I, Inc. (Biocare)
Agilent implemented FY26 workforce reduction targeting $30M to $35M in annual cost savings
In Q3 FY26, Agilent announced and implemented a new workforce reduction plan across all three business segments, incurring $15 million in restructuring costs and expecting completion by Q1 FY27.
Agilent issues $600 million senior notes due 2032 with 4.90% coupon
On June 25, 2026, Agilent issued $600 million in aggregate principal amount of 4.90% senior notes maturing in January 2032.
$600M
aggregate principal amount of 2032 senior notes issued
4.9%
fixed interest rate per annum
Agilent targets $30 million to $35 million in annual savings from FY26 restructuring
Agilent expects its newly implemented FY26 restructuring program to reduce annual cost of revenue and operating expenses by $30 million to $35 million when completed by Q1 FY27.
$35M
estimated high end of annual reduction in cost of revenue and operating expenses from FY26 Plan
- SEC EDGAR
10-Q · Quarter ended Apr 30, 2026
Filed · 4 signals
Agilent enters definitive agreement to acquire Biocare for approximately $950 million in cash
On March 6, 2026, Agilent agreed to acquire 100 percent of BC Midco I, Inc.
$950M
aggregate purchase price in cash to acquire Biocare
Agilent expects $90 million to $95 million savings from FY25 restructuring workforce reductions
Agilent recorded $8 million and $28 million in restructuring costs for the three and six months ended April 30, 2026, under its FY25 Plan to optimize management structure.
$90M
annual cost of revenue and operating expense reduction from restructuring
- SEC EDGAR
10-Q · Quarter ended Jan 31, 2026
Filed · 5 signals
Agilent executes FY25 restructuring plan targeting $90M to $95M in annual cost reductions
Agilent reported that its FY25 restructuring plan is estimated to reduce annual cost of sales and operating expenses by approximately $90 million to $95 million across all three business segments when completed.
$90M
annual cost of sales and operating expense reductions across three business segments
Agilent records $20 million in quarterly restructuring charges under ongoing FY25 plan
Agilent recorded $20 million in restructuring and related costs for the quarter ended January 31, 2026, bringing total plan expense to $101 million with $16 million in remaining accrued liability.
$20M
restructuring and other related costs recorded in the quarter
Life Sciences and Diagnostics revenue grew 17% in Asia Pacific and 7% in Europe
For the three months ended January 31, 2026, Agilent reported strong regional revenue gains of 17 percent in Asia Pacific and 7 percent in Europe for its Life Sciences and Diagnostics Markets segment, despite a 2 percent decline in the Americas.
17%
revenue increase in Asia Pacific for Life Sciences and Diagnostics Markets
liquid chromatographyliquid chromatography mass spectrometry
Agilent operating margin decreases 3 percentage points due to tariffs and restructuring costs
Total operating margin declined 3 percentage points year-over-year to 19.7% for the quarter ended January 31, 2026, impacted by higher tariffs, corporate infrastructure costs, restructuring charges, and transformational expenses.
19.7%
operating margin for the three months ended January 31, 2026
Showing 10 of 14 filing signals. The Signal API returns all of them.
Get them with one API callEarnings calls
Agilent earnings headlines
From earnings call transcripts (Signal API type earnings-transcripts).
| Call date | What the company said |
|---|---|
| Secured $9M TSA contract expansion for Raman Insight securityAgilent expanded its initial $9 million contract win with the TSA for the Raman Insight series, expanding deployments from FIFA World Cup host cities to additional U.S. airports. Both the Insight BRT and Insight300 systems achieved new regulatory detection certifications in the U.S. and Europe, opening doors for broader RFPs. This demonstrates strong government procurement traction in... | |
| Mobilized AI enterprise partnerships with OpenAI and BCG XAgilent moved its enterprise AI strategy into active execution by mobilizing partnerships with OpenAI and BCG X. The initiative focuses on building an AI center of excellence, transforming internal software development lifecycles, and accelerating commercial customer journey workflows. This highlights enterprise AI deployment and vendor collaboration opportunities for software and data tooling. | |
| Ignite operating system delivered 200 bps strategic pricing benefitAgilent generated approximately 200 basis points of pricing benefit in Q3 via its Ignite Operating System, surpassing its full-year target of over 100 basis points. Operating margins expanded by 210 basis points year-over-year excluding tariff refunds, supported by an internally developed AI supply chain control tower and a distributed regional manufacturing model. Management continues to... | |
| Customer onboarding and support satisfaction reached record 95% levelOver 85% of surveyed Agilent customers rated their experience as highly favorable across purchasing, onboarding, solution use, and support. Satisfaction specifically for onboarding and support set an all-time record at 95% or above, matching a 95% on-time delivery rate. Maintaining elevated customer experience scores serves as a foundational pillar for Agilent's CrossLab multi-year service... | |
| Online order volume grew low teens via agilent.com initiativesAgilent's digital transformation initiatives generated low-teens growth in new online orders on agilent.com during the third quarter. The program aims to streamline digital procurement, improve direct customer engagement, and lower the internal transaction cost per order. This highlights continuing investments into digital commercial infrastructure and laboratory e-commerce platforms. | |
| Managing rising material costs and supply chain inflation headwindsAgilent is actively navigating headwinds from rising material costs, general inflation, and supply chain frictions. To counteract these pressures, the company raised inventory buffers slightly and deployed regional manufacturing hubs in Asia without adding headcount. Suppliers offering cost-optimization, supply chain visibility, and logistics resilience software can find engagement... |
Signal API · MCP
Track Agilent with the Signal API
One POST /v1/companies/enrich call with agilent.com returns Agilent 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"agilent.com","signal_types":["sec-10q"],"limit":20}'Bulk data
Need this signal for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.
Same industry
10-Q at related companies
Questions about Agilent 10-Q
When did Agilent file its latest 10-Q?
What did Agilent disclose in its latest 10-Q?
What did Agilent say on its recent earnings calls?
Where can I read Agilent's 10-Q filing?
Page updated , the date of the newest row on this page.
Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .